Leaders in Pharmaceutical Business Intelligence (LPBI) Group

New Dean for Faculty of Medicine, HMS, George Q. Daley will assume leadership role at HMS on Jan. 1, 2017

Reporter: Aviva Lev-Ari, PhD, RN

SOURCE

http://hms.harvard.edu/news/new-dean-faculty-medicine?utm_source=Silverpop&utm_medium=email&utm_content=s1&utm_campaign=08.15.16.HMS

A graduate of Harvard College and HMS with a PhD in biology from the Massachusetts Institute of Technology, Daley currently serves as professor of biological chemistry and molecular pharmacology and as the Robert A. Stranahan Professor of Pediatrics at HMS, as well as director of the Stem Cell Transplantation Program at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. He will take up his new duties on Jan. 1, 2017.

After earning his bachelor’s degree magna cum laude from Harvard in 1982, Daley went on to earn his PhD in biology (1989) at MIT, working in David Baltimore’s laboratory at the MIT-affiliated Whitehead Institute for Biomedical Research. He received his MD from HMS, graduating in 1991 with the rare distinction of summa cum laude. He then pursued clinical training in internal medicine at Mass General and was a clinical fellow at Brigham and Women’s and Boston Children’s hospitals. While running a laboratory as a Whitehead Fellow at the Whitehead Institute, he joined the HMS faculty as an assistant professor in 1995, was promoted to associate professor in 2004, was named to an endowed chair at Boston Children’s in 2009, and became a full professor at HMS in 2010.

Daley was an inaugural winner of the National Institutes of Health Director’s Pioneer Award for highly innovative research (2004). His numerous honors include the American Philosophical Society’s Judson Daland Prize for achievement in patient-oriented research, the American Pediatric Society’s E. Mead Johnson Award for contributions to stem cell research, the American Society of Hematology’s E. Donnall Thomas Prize for advances in human-induced pluripotent stem cells, and the International Chronic Myeloid Leukemia Foundation’s Janet Rowley Prize for outstanding lifetime contributions to the understanding and/or treatment of the disease. He is an elected member of the National Academy of Medicine and the American Society for Clinical Investigation, among other professional societies.

SOURCES

http://hms.harvard.edu/news/new-dean-faculty-medicine?utm_source=Silverpop&utm_medium=email&utm_content=s1&utm_campaign=08.15.16.HMS

New dean for Faculty of Medicine